CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 20 enrolled
Drug / intervention
LC beads loaded with Doxorubicindevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01010984
NCT01010984N/ACompleted
CompareCT.gov

Transcatheter Arterial Chemoembolization With Doxorubicin-loaded LC Beads in the Treatment of Liver-dominant Metastases in Patients With Stage IV Metastatic Melanoma

Robert C. Martin·interventional·Posted Nov 10, 2009·Updated Oct 25, 2018

In Brief

A clinical study evaluating LC beads loaded with Doxorubicin for Stage IV Melanoma. Completed, enrolled 20 participants across 3 sites.

Detailed Summary

The purpose of this study is to determine if LC beads loaded with Doxorubicin are a safe and effective treatment for melanoma that has spread to the liver.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsStage IV Melanoma
CountriesUnited States
CollaboratorsUniversity of Louisville, Thomas Jefferson University, M.D. Anderson Cancer Center

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedNov 10, 2009
Enrollment StartSep 1, 2009
Primary CompletionDec 1, 2012
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 16.6 years ago

Interventions

LC beads loaded with Doxorubicindevice

During each TACE, 2 vials (1 vial, 75mg Doxorubicin) of 100-300 micrometer size LC beads loaded with doxorubicin will be delivered to the liver tumor(s). Total Doxorubicin dose for each TACE is 150mg